Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium

Opening hours:
Mon to Thu: 10h - 12h30 and 13h30 - 17h
Fri: 10h - 12h30 and 13h30 - 16h


+3226269640
Google maps


Find us on
Google Maps
To subscribe to our newsletter, please click here. If you would like to become an EATG member, please fill in the form here. You can also subscribe to our RSS feed by clicking here.
You can also follow us on one of these media :
TAGS

22/10/2014
Enanta Pharmaceuticals provides update on its collaboration agreement with AbbVie

Co-Development Option on Next-Generation Protease Inhibitor ABT-493 Not Exercised Net Sales Allocations for ABT-450-Containing Regimens Finalized WATERTOWN, Mass.--(BUSINESS WIRE)--Oct. 20, 2014-- Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field,...

Read more...





22/10/2014
No to treating our way out of the epidemic, say South African experts

No, we cannot treat our way out of the HIV epidemic, was the resounding sentiment of a panel of expert clinicians and the audience, at a debate held at the 2014 Southern African HIV Clinicians Conference in Cape Town last month. Professor Richard Chaisson of the Johns Hopkins University School of Medicine argued that antiretroviral therpay is essential to decrease the...

Read more...

Source Source: Aidsmap





20/10/2014
Long-term HIV infection and health-related quality of life

The widespread availability of potent combination anti-HIV therapy (commonly called ART or HAART) has greatly reduced deaths from AIDS-related infections in Canada and other high-income countries. The benefit of ART is so profound that researchers increasingly expect that some young adults who are infected today and who begin treatment shortly thereafter will likely live into their...

Read more...

Source Source: CATIE





20/10/2014
LabCorp introduces HIV-1 next generation sequencing assay to support drug regimen changes in HIV suppressed patients

GenoSure Archive SM is the first genotypic drug resistance assay to interrogate HIV-1 DNA October 20, 2014 08:45 AM Eastern Daylight Time BURLINGTON, N.C.--Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) and Monogram Biosciences, Inc., part of the LabCorp Specialty Testing Group, today announced the launch of...

Read more...

Source Source: Business Wire





20/10/2014
WHO recommends steps to improve HIV/AIDS control in Estonia

Estonia is among 5 European Union/European Economic Area countries with the highest rates of HIV– 24.6 per 100 000 populations in 2013. While the number of new HIV cases has been decreasing in Estonia since 2001, more needs to be done to address shortcomings in HIV/AIDS surveillance, treatment and care in order to halt the epidemic.  These are among the conclusions...

Read more...

Source Source: WHO/Europe